AmEx Pharmacy Voluntarily Recalls Bevacizumab

August 30, 2019 – Pacifico National, doing business as AmEx Pharmacy, has announced the voluntary recall of all lots of Bevacizumab 1.25mg/0.05ml 31g Injectable and all lots of Bevacizumab 2.5mg/0.1ml Norm-Ject TB Injectable that are within expiry to the healthcare provider level. The products have been recalled out of an abundance of caution following an FDA inspection.

According to AmEx, there is a risk the affected products may not be sterile. This creates a risk of infection for patients who receive the affected products, which are intended for sterile injection by a qualified healthcare provider. The products are used to treat wet age-related macular degeneration and diabetic retinopathy. They are individually wrapped and labeled in a Tyvek pouch, which is then placed in a labeled amber bag to protect the product from light.

AmEx Pharmacy is notifying its consignees by email and overnight mail and is arranging for return of all recalled product. Administering physicians who have the product in stock should discontinue its use, remove it from inventory, and return the recalled product to AmEx Pharmacy. Patients who have questions regarding the recall should contact AmEx Pharmacy by phone at 1-800-644-9431 or by email at amargio@amexpharmacy.com. If a patient has experienced issues that may be related to the administration of the recalled product, they should contact their healthcare provider. Adverse events can also be reported to the U.S. FDA’s MedWatch program.

Full details of the recall are available on the FDA's website.

Benecard Central Fill has not distributed the affected product.